Cardiac Angiogenic Imbalance Leads to Peripartum Cardiomyopathy

DSpace/Manakin Repository

Cardiac Angiogenic Imbalance Leads to Peripartum Cardiomyopathy

Citable link to this page

 

 
Title: Cardiac Angiogenic Imbalance Leads to Peripartum Cardiomyopathy
Author: Patten, Ian S.; Farrell, Caitlin; Tudorache, Igor; Bauersachs, Johann; Hilfiker-Kleiner, Denise; Rana, Sarosh; Shahul, Sajid Saleem; Rowe, Glenn C; Jang, Cholsoon; Liu, Laura; Hacker, Michele Renee; Rhee, Julie S; Mitchell, John D.; Mahmood, Feroze-Ud-Den; Hess, Philip E.; Koulisis, Nicole; Khankin, Eliyahu; Burke, Suzanne Diana; Del Monte, Federica; Karumanchi, Subbian Ananth; Arany, Zoltan Pierre

Note: Order does not necessarily reflect citation order of authors.

Citation: Patten, Ian S., Sarosh Rana, Sajid Saleem Shahul, Glenn C. Rowe, Cholsoon Jang, Laura Liu, Michele Renee Hacker, et al. 2012. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485(7398): 333-338.
Full Text & Related Files:
Abstract: Peripartum cardiomyopathy (PPCM) is an often fatal disease that affects pregnant women who are near delivery, and it occurs more frequently in women with pre-eclampsia and/or multiple gestation. The aetiology of PPCM, and why it is associated with pre-eclampsia, remain unknown. Here we show that PPCM is associated with a systemic angiogenic imbalance, accentuated by pre-eclampsia. Mice that lack cardiac PGC-\(1\alpha\), a powerful regulator of angiogenesis, develop profound PPCM. Importantly, the PPCM is entirely rescued by pro-angiogenic therapies. In humans, the placenta in late gestation secretes VEGF inhibitors like soluble FLT1 (sFLT1), and this is accentuated by multiple gestation and pre-eclampsia. This anti-angiogenic environment is accompanied by subclinical cardiac dysfunction, the extent of which correlates with circulating levels of sFLT1. Exogenous sFLT1 alone caused diastolic dysfunction in wild-type mice, and profound systolic dysfunction in mice lacking cardiac PGC-\(1\alpha\). Finally, plasma samples from women with PPCM contained abnormally high levels of sFLT1. These data indicate that PPCM is mainly a vascular disease, caused by excess anti-angiogenic signalling in the peripartum period. The data also explain how late pregnancy poses a threat to cardiac homeostasis, and why pre-eclampsia and multiple gestation are important risk factors for the development of PPCM.
Published Version: doi:10.1038/nature11040
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356917/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10579232
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters